SCHEMBL9766002

SCHEMBL9766002

Fc1cnc(N2CCN(c3ccc(F)c4ccccc34)CC2)nc1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 8/20 0.58
HTR1A P08908 4/20 0.43
CYP2D6 P10635 1/20 0.42
GAA P10253 3/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HSD17B10 Q99714 1/20 0.41
HTT P42858 1/20 0.40
DRD2 P14416 2/20 0.39
HTR2A P28223 1/20 0.39
KDM4E B2RXH2 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9766068 0.74 SIGMAR1 (1.00) SIGMAR1HTR1AGAADRD2HTR2A
Ammonia Solution, Strong SCHEMBL9765999 0.73 SIGMAR1 (0.98) SIGMAR1HTR1AGAADRD2HTR2A
SCHEMBL31585883 0.73 ALDH1A1 (0.57) SIGMAR1GAAALDH1A1MAPTSMN1; SMN2
SCHEMBL5362969 0.72 HTR6 (0.65) SIGMAR1HTR1ACYP2D6ALDH1A1HPGD
SCHEMBL9766006 0.72 SIGMAR1 (1.00) SIGMAR1HTR1AGAADRD2KDM4E
SCHEMBL9766069 0.71 SIGMAR1 (0.67) SIGMAR1HTR1AGAADRD2HTR2A
SCHEMBL9766055 0.71 SIGMAR1 (0.64) SIGMAR1HTR1ACYP2D6GAASMN1; SMN2
Hydrochloric Acid SCHEMBL9766032 0.71 SIGMAR1 (0.98) SIGMAR1HTR1AGAADRD2KDM4E
SCHEMBL24126297 0.68 SIGMAR1 (0.46) SIGMAR1HTR1ACYP2D6GAADRD2
SCHEMBL31585530 0.68 ALDH1A1 (0.63) GAAALDH1A1MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4994460-A Treatment or prevention of disorders resulting from central nervous system anoxia BRISTOL-MYERS SQUIBB CO. (US) 1991-02-19 US disclosed
EP-0400661-A1 Agents for treatment of brain ischemia Bristol-Myers Squibb Company (US) 1990-12-05 EP disclosed